These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11054667)

  • 1. Overexpression of the csk gene suppresses tumor metastasis in vivo.
    Nakagawa T; Tanaka S; Suzuki H; Takayanagi H; Miyazaki T; Nakamura K; Tsuruo T
    Int J Cancer; 2000 Nov; 88(3):384-91. PubMed ID: 11054667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo suppression of osteoclast function by adenovirus vector-induced csk gene.
    Miyazaki T; Takayanagi H; Isshiki M; Takahashi T; Okada M; Fukui Y; Oda H; Nakamura K; Hirai H; Kurokawa T; Tanaka S
    J Bone Miner Res; 2000 Jan; 15(1):41-51. PubMed ID: 10646113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of arthritic bone destruction by adenovirus-mediated csk gene transfer to synoviocytes and osteoclasts.
    Takayanagi H; Juji T; Miyazaki T; Iizuka H; Takahashi T; Isshiki M; Okada M; Tanaka Y; Koshihara Y; Oda H; Kurokawa T; Nakamura K; Tanaka S
    J Clin Invest; 1999 Jul; 104(2):137-46. PubMed ID: 10411542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Csk defines the ability of integrin-mediated cell adhesion and migration in human colon cancer cells: implication for a potential role in cancer metastasis.
    Rengifo-Cam W; Konishi A; Morishita N; Matsuoka H; Yamori T; Nada S; Okada M
    Oncogene; 2004 Jan; 23(1):289-97. PubMed ID: 14712234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of bovine thymus cytosolic C-terminal Src kinase (CSK) and demonstration of differential efficiencies of phosphorylation and inactivation of p56lyn and pp60c-src by CSK.
    Cheng HC; Bjorge JD; Aebersold R; Fujita DJ; Wang JH
    Biochemistry; 1996 Sep; 35(36):11874-87. PubMed ID: 8794770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Src family tyrosine kinases-driven colon cancer cell invasion is induced by Csk membrane delocalization.
    Sirvent A; Bénistant C; Pannequin J; Veracini L; Simon V; Bourgaux JF; Hollande F; Cruzalegui F; Roche S
    Oncogene; 2010 Mar; 29(9):1303-15. PubMed ID: 20010872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased CHK protein levels are associated with Src activation in colon cancer cells.
    Zhu S; Bjorge JD; Cheng HC; Fujita DJ
    Oncogene; 2008 Mar; 27(14):2027-34. PubMed ID: 17934522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK)--endogenous negative regulators of Src-family protein kinases.
    Chong YP; Mulhern TD; Cheng HC
    Growth Factors; 2005 Sep; 23(3):233-44. PubMed ID: 16243715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced C-terminal Src kinase (Csk) activities in hepatocellular carcinoma.
    Masaki T; Okada M; Tokuda M; Shiratori Y; Hatase O; Shirai M; Nishioka M; Omata M
    Hepatology; 1999 Feb; 29(2):379-84. PubMed ID: 9918913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRL3 promotes cell invasion and proliferation by down-regulation of Csk leading to Src activation.
    Liang F; Liang J; Wang WQ; Sun JP; Udho E; Zhang ZY
    J Biol Chem; 2007 Feb; 282(8):5413-9. PubMed ID: 17192274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiproliferative effect of sulindac in colonic neoplasia prevention: role of COOH-terminal Src kinase.
    Kunte DP; Wali RK; Koetsier JL; Roy HK
    Mol Cancer Ther; 2008 Jul; 7(7):1797-806. PubMed ID: 18644992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for epidermal growth factor receptor, c-Src and focal adhesion kinase in an in vitro model for the progression of colon cancer.
    Brunton VG; Ozanne BW; Paraskeva C; Frame MC
    Oncogene; 1997 Jan; 14(3):283-93. PubMed ID: 9018114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitotic activation of c-Src is suppressed by Csk.
    Ohsato Y; Nada S; Okada M; Nakagawa H
    Jpn J Cancer Res; 1994 Oct; 85(10):1023-8. PubMed ID: 7525522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have c-src upregulation.
    Kanou T; Oneyama C; Kawahara K; Okimura A; Ohta M; Ikeda N; Shintani Y; Okumura M; Okada M
    Mol Cancer Res; 2011 Jan; 9(1):103-14. PubMed ID: 21156787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lipid raft-anchored adaptor protein Cbp controls the oncogenic potential of c-Src.
    Oneyama C; Hikita T; Enya K; Dobenecker MW; Saito K; Nada S; Tarakhovsky A; Okada M
    Mol Cell; 2008 May; 30(4):426-36. PubMed ID: 18498747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dok-R mediates attenuation of epidermal growth factor-dependent mitogen-activated protein kinase and Akt activation through processive recruitment of c-Src and Csk.
    Van Slyke P; Coll ML; Master Z; Kim H; Filmus J; Dumont DJ
    Mol Cell Biol; 2005 May; 25(9):3831-41. PubMed ID: 15831486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Csk-binding protein (Cbp) negatively regulates epidermal growth factor-induced cell transformation by controlling Src activation.
    Jiang LQ; Feng X; Zhou W; Knyazev PG; Ullrich A; Chen Z
    Oncogene; 2006 Sep; 25(40):5495-506. PubMed ID: 16636672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide and protein phosphorylation by protein tyrosine kinase Csk: insights into specificity and mechanism.
    Sondhi D; Xu W; Songyang Z; Eck MJ; Cole PA
    Biochemistry; 1998 Jan; 37(1):165-72. PubMed ID: 9425036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-terminal Src kinase (CSK) modulates insulin-like growth factor-I signaling through Src in 3T3-L1 differentiation.
    Sekimoto H; Boney CM
    Endocrinology; 2003 Jun; 144(6):2546-52. PubMed ID: 12746317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperative role of caveolin-1 and C-terminal Src kinase binding protein in C-terminal Src kinase-mediated negative regulation of c-Src.
    Place AT; Chen Z; Bakhshi FR; Liu G; O'Bryan JP; Minshall RD
    Mol Pharmacol; 2011 Oct; 80(4):665-72. PubMed ID: 21778303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.